Short hairpin RNAs, or short hairpin RNAs (shRNAs), are a proven tool for gene knockdown and a promising therapeutic approach for suppression of disease-associated genes. The efficient preparation of shRNA-expressing vectors can sometimes become a bottleneck due to the complexity of shRNA hairpin sequence and structure, especially for repetitive or high GC-content targets. Here, we present improved shRNA cloning and validation methods that enabled efficient and rapid cloning of several shRNAs targeting disease-associated repeat expansions, including GGGGCC, CAG, CTG, CCTG, and CGG into modified pLKO.1 vectors. Improvements included shRNA insert design and preparation, recombination-based cloning, and sequencing-based validation that included Sanger and nanopore long-read sequencing. This improved method should enable practical, efficient cloning of nearly any shRNA sequence.
Get full access to this article
View all access options for this article.
References
1.
PaddisonPJ, CaudyAA, BernsteinE, et al.Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev, 2002; 16:948–958.
2.
ElbashirSM, HarborthJ, LendeckelW, et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001; 411:494–498.
3.
FireA, XuS, MontgomeryMK, et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998; 391:806–811.
4.
Lagos-QuintanaM, RauhutR, LendeckelW, et al.Identification of novel genes coding for small expressed RNAs. Science, 2001; 294:853–858.
5.
LeeRC, FeinbaumRL, AmbrosV. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993; 75:843–854.
6.
ReinhartBJ, SlackFJ, BassonM, et al.The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000; 403:901–906.
7.
ZamorePD, TuschlT, SharpPA, et al.RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 2000; 101:25–33.
8.
LewisBP, ShihIH, Jones-RhoadesMW, et al.Prediction of mammalian microRNA targets. Cell, 2003; 115:787–798.
9.
BartelDP.MicroRNAs: target recognition and regulatory functions. Cell, 2009; 136:215–233.
10.
LeeY, AhnC, HanJ, et al.The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003; 425:415–419.
11.
DenliAM, TopsBB, PlasterkRH, et al.Processing of primary microRNAs by the Microprocessor complex. Nature, 2004; 432:231–235.
12.
MacRaeIJ, MaE, ZhouM, et al.In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci U S A, 2008; 105:512–517.
13.
ElkayamE, KuhnCD, TociljA, et al.The structure of human argonaute-2 in complex with miR-20a. Cell, 2012; 150:100–110.
14.
LiuY, YeX, JiangF, et al.C3PO, an endoribonuclease that promotes RNAi by facilitating RISC activation. Science, 2009; 325:750–753.
15.
TakimotoK, WakiyamaM, YokoyamaS. Mammalian GW182 contains multiple Argonaute-binding sites and functions in microRNA-mediated translational repression. RNA, 2009; 15:1078–1089.
16.
PartinAC, ZhangK, JeongBC, et al.Cryo-EM structures of human drosha and DGCR8 in complex with primary microRNA. Mol Cell, 2020; 78:411–422 e414.
17.
MeisterGL, M, PatkaniowskaA, DorsettY, et al.Human argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell, 2004; 15:185–197.
18.
WangHW, NolandC, SiridechadilokB, et al.Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol, 2009; 16:1148–1153.
19.
LiuJ, CarmellMA, RivasFV, et al.Argonaute2 is the catalytic engine of mammalian RNAi. Science, 2004; 305:1437–1441.
20.
ToliaNH, Joshua-TorL. Slicer and the argonautes. Nat Chem Biol, 2007; 3:36–43.
21.
HockJ, MeisterG. The Argonaute protein family. Genome Biol, 2008; 9:210.
22.
McManusMT, PetersenCP, HainesBB, et al.Gene silencing using micro-RNA designed hairpins. RNA, 2002; 8:842–850.
23.
MoffatJ, GruenebergDA, YangX, et al.A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell, 2006; 124:1283–1298.
24.
HassonSA, KaneLA, YamanoK, et al.High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy. Nature, 2013; 504:291–295.
25.
XieJ, TaiPWL, BrownA, et al.Effective and Accurate Gene Silencing by a Recombinant AAV-Compatible MicroRNA Scaffold. Mol Ther, 2020; 28:422–430.
26.
MartierR, LiefhebberJM, Garcia-OstaA, et al.Targeting RNA-mediated toxicity in C9orf72 ALS and/or FTD by RNAi-based gene therapy. Mol Ther Nucleic Acids, 2019; 16:26–37.
27.
Kotowska-ZimmerA, PewinskaM, OlejniczakM. Artificial miRNAs as therapeutic tools: challenges and opportunities. Wiley Interdisc Rev RNA, 2021; 12:e1640.
28.
ShengP, FloodKA, XieM. Short hairpin RNAs for strand-specific small interfering RNA production. Front Bioeng Biotechnol, 2020; 8:940.
29.
FangW, BartelDP. The menu of features that define primary microRNAs and enable de novo design of microRNA genes. Mol Cell, 2015; 60:131–145.
30.
LewisBP, BurgeCB, BartelDP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005; 120:15–20.
31.
AgarwalV, BellGW, NamJW, et al.Predicting effective microRNA target sites in mammalian mRNAs. eLife, 2015; 4.
32.
MiniarikovaJ, ZanellaI, HuseinovicA, et al.Design, characterization, and lead selection of therapeutic miRNAs targeting huntingtin for development of gene therapy for Huntington's disease. Mol Ther Nucleic Acids, 2016; 5:e297.
33.
CiesiolkaA, Stroynowska-CzerwinskaA, JoachimiakP, et al.Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts. Cell Mol Life Sci, 2021; 78:1577–1596.
34.
DeJesus-HernandezM, MackenzieIR, BoeveBF, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 2011; 72:245–256.
35.
RentonAE, MajounieE, WaiteA, et al.A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 2011; 72:257–268.
36.
HuJ, MatsuiM, GagnonKT, et al.Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat Biotechnol, 2009; 27:478–484.
37.
GagnonKT, PendergraffHM, DeleaveyGF, et al.Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry, 2010; 49:10166–10178.
38.
HuJX, GagnonKT, LiuJ, et al.Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs. Biol Chem, 2011; 392:315–325.
39.
HuJ, LiuJ, LiL, et al.Engineering duplex RNAs for challenging targets: recognition of GGGGCC/CCCCGG repeats at the ALS/FTD C9orf72 locus. Chem Biol, 2015; 22:1505–1511.
40.
RohillaKJ, OvingtonKN, PaterAA, et al.Systematic microsatellite repeat expansion cloning and validation. Human Genet, 2020; 139:1233–1246.
41.
ShabardinaV, KischkaT, ManskeF, et al.NanoPipe-a web server for nanopore MinION sequencing data analysis. GigaScience, 2019; 8.
GiesselmannP, BrandlB, RaimondeauE, et al.Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing. Nat Biotechnol, 2019; 37:1478–1481.
44.
SoneJ, MitsuhashiS, FujitaA, et al.Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet, 2019; 51:1215–1221.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
